Page last updated: 2024-08-17

aldosterone and fimasartan

aldosterone has been researched along with fimasartan in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cho, JY; Jang, IJ; Kim, TE; Shin, SG; Yi, S; Yoon, SH; Yu, KS1
Cho, JY; Jang, IJ; Jeon, H; Kim, J; Lim, KS; Shin, KH; Shin, SG; Yoon, SH; Yu, KS1
Cho, JY; Gu, N; Jang, IJ; Rhee, MY; Shin, KH1

Trials

3 trial(s) available for aldosterone and fimasartan

ArticleYear
Pharmacokinetic interaction of fimasartan, a new angiotensin II receptor antagonist, with amlodipine in healthy volunteers.
    Journal of cardiovascular pharmacology, 2011, Volume: 57, Issue:6

    Topics: Adult; Aldosterone; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Interactions; Humans; Male; Metabolic Clearance Rate; Pyrimidines; Renin; Tetrazoles; Young Adult

2011
Assessment of the drug-drug interactions between fimasartan and hydrochlorothiazide in healthy volunteers.
    Journal of cardiovascular pharmacology, 2012, Volume: 59, Issue:1

    Topics: Administration, Oral; Adult; Aldosterone; Antihypertensive Agents; Biphenyl Compounds; Chromatography, High Pressure Liquid; Drug Interactions; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Male; Middle Aged; Pyrimidines; Renin; Tandem Mass Spectrometry; Tetrazoles; Young Adult

2012
The influence of dietary sodium content on the pharmacokinetics and pharmacodynamics of fimasartan.
    Drug design, development and therapy, 2016, Volume: 10

    Topics: Adult; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Cross-Over Studies; Dose-Response Relationship, Drug; Healthy Volunteers; Humans; Male; Middle Aged; Pyrimidines; Renin; Sodium, Dietary; Tetrazoles; Young Adult

2016